knowledge -WSS

knowledge

author：leisure time 2025-09-06 05:40:51 - browse：95841

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Stem cell clinics for heart failure: buyer be wary

WSS

Influencer to be charged after chaos erupts in New York City's Union Square

Life sciences deals on track to hit lowest point since 2017

Readout LOUD podcast: Merger Mondays, Ozempic panic

A revolution in caring for preterm infants

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

explore

knowledge

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

STAT Readout: Today's biotech news includes Sana and Amylyx

Medical records are filled with copy

What Mike Pence has said that could be used in a Donald Trump trial

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Gilgo Beach: Police identify another victim in serial killing investigation

Guidelines to prevent youth baseball injuries need more muscle

Nick Jonas talks about managing diabetes along with his career

Affirmative action in medical school literally saved lives

What's changing in Medicare's open enrollment this year?

focus

Humana CEO Bruce Broussard to step down in 2024

For BCIs, commercial hurdles may be bigger than scientific ones

Medicare to cover more brain scans related to Alzheimer’s drugs

Medicare to cover more brain scans related to Alzheimer’s drugs

Attacks on the drug industry will lead to fewer breakthroughs

Attacks on the drug industry will lead to fewer breakthroughs

leisure time

leisure time

Wikipedia

hotspot